MACM
WST icon

March Altus Capital Management’s West Pharmaceutical WST Stock Holding History

March Altus Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-210,910
Closed -$11.2M – 21
2014
Q4 		$11.2M Buy
210,910
+72,112
+52% +$3.61M 5.13% 9
2014
Q3 		$6.21M Buy
138,798
+126,167
+999% +$5.36M 2.47% 20
2014
Q2 		$533K Sell
12,631
-196,170
-94% -$8.4M 0.2% 30
2014
Q1 		$9.2M Sell
208,801
-128,360
-38% -$6.04M 2.95% 18
2013
Q4 		$16.5M Buy
+337,161
New +$15.8M 5.01% 5

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

March Altus Capital Management's WST Position: Q1 2015 in Review

March Altus Capital Management sold out of West Pharmaceutical (WST) in Q1 2015, closing a stake of 210,910 shares — an estimated $11.2M sold.

March Altus Capital Management first reported a position in WST in Q4 2013 and held it in 5 quarters. The position peaked at $16.5M in Q4 2013. 214 funds tracked by Wall St. Rank hold WST as of Q1 2015.

  • March Altus Capital Management reported no remaining West Pharmaceutical position as of Q1 2015 after selling out during the quarter.
  • March Altus Capital Management sold 210,910 West Pharmaceutical shares in Q1 2015, an estimated $11.2M.
  • March Altus Capital Management first reported a position in West Pharmaceutical in Q4 2013 and held it in 5 quarters.
  • March Altus Capital Management's West Pharmaceutical position peaked at $16.5M in Q4 2013.
  • 214 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2015.

Based on March Altus Capital Management's 13F filing for Q1 2015, filed 15 May 2015.